These 20 women are 2018's Fiercest in the life sciences industry.
Read 2018's Fiercest Women in Life Sciences report!
The past week’s biotech news included a method for regrowing nerves by turning off genes and a potential combo to treat resistant lung cancer.
A Penn team used gene editing to screen for harmful variants of a gene that causes severe hypertrophic cardiomyopathy.
A team of Stanford University scientists has found a way to direct a regenerative diabetes medicine to the right cells more precisely.
Neurimmune's antibody targets the misfolded SOD1 protein that has been implicated in a subset of ALS cases.
Aussie scientists say that blocking the RCAN1 gene helps the body turn unhealthy white fat into calorie-burning brown fat.
The week’s news included antibodies that lower the risks of bone marrow transplants and a new way to target a mutation in epilepsy.
UCLA scientists say they’re closer to understanding the genes involved in the overproduction of the neuron-damaging protein tau.
At ASH, Fate will present preclinical data on three off-the-shelf, cancer-fighting cell therapies made from stem cells.
Using a library of gRNA-target pairs, Wellcome Sanger Institute scientists have developed a tool to predict CRISPR editing errors.
MIT scientists designed a material that allows osteoarthritis drugs to more deeply penetrate cartilage-generating tissues.
